EDGAR Filing Documents for 0001193125-13-095969

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:

SEC Accession No. 0001193125-13-095969

Filing Date

2013-03-07

Accepted

2013-03-07 16:02:36

Documents

Period of Report

2012-12-31

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 10-K	d453089d10k.htm	10-K	1112456
2	EX-23.1	d453089dex231.htm	EX-23.1	1938
3	EX-23.2	d453089dex232.htm	EX-23.2	1673
4	EX-31.1	d453089dex311.htm	EX-31.1	9503
5	EX-31.2	d453089dex312.htm	EX-31.2	9674
6	EX-32.1	d453089dex321.htm	EX-32.1	3771
7	EX-32.2	d453089dex322.htm	EX-32.2	3968
14	GRAPHIC	g453089g88o30.jpg	GRAPHIC	49550
	Complete submission text file	0001193125-13-095969.txt		7738678

Data Files

Seq	Description	Document	Type	Size
8	XBRL INSTANCE DOCUMENT	thld-20121231.xml	EX-101.INS	1254131
9	XBRL TAXONOMY EXTENSION SCHEMA	thld-20121231.xsd	EX-101.SCH	72154
10	XBRL TAXONOMY EXTENSION CALCULATION LINKBASE	thld-20121231_cal.xml	EX-101.CAL	60807
11	XBRL TAXONOMY EXTENSION DEFINITION LINKBASE	thld-20121231_def.xml	EX-101.DEF	365506
12	XBRL TAXONOMY EXTENSION LABEL LINKBASE	thld-20121231_lab.xml	EX-101.LAB	524822
13	XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE	thld-20121231_pre.xml	EX-101.PRE	428536

Mailing Address 170 HARBOR WAY SUITE 300 SOUTH SAN FRANCISCO CA 94080

Business Address 170 HARBOR WAY SUITE 300 SOUTH SAN FRANCISCO CA 94080 650 474 8200

THRESHOLD PHARMACEUTICALS INC (Filer) CIK: 0001183765 (see all company filings)